Announcement on Voluntary Disclosure of Approval of ALK Inhibitor Conteltinib Granules (Shouyaoze®) for Marketing by the National Medical Products Administration
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment